申请人:Merck & Co., Inc.
公开号:EP0122321A1
公开(公告)日:1984-10-24
Hydroxybenzylamino derivatives have been prepared from an appropriate hydroxybenzaldehyde and an amine followed by reduction. These compounds are found to be active topical anti-inflammatory agents.
羟基苄氨基衍生物是由适当的羟基苯甲醛和胺经过还原制备而成的。这些化合物被发现是具有活性的局部消炎剂。